MUR
49
4
F
47
3
ZION
52
2
DUK
64
-5
PM
56
-8
CPB
65
11
EFX
69
-6
GE
82
-2
ROP
60
-5
T
60
-3
NTRS
49
2
VLO
42
2
RF
50
3
GOOG
61
2
JPM
55
2
R
67
4
HRL
36
-2
VZ
47
-5
AEP
62
-4
ACN
43
-13
MUR
49
4
F
47
3
ZION
52
2
DUK
64
-5
PM
56
-8
CPB
65
11
EFX
69
-6
GE
82
-2
ROP
60
-5
T
60
-3
NTRS
49
2
VLO
42
2
RF
50
3
GOOG
61
2
JPM
55
2
R
67
4
HRL
36
-2
VZ
47
-5
AEP
62
-4
ACN
43
-13
Financhill
Back

Marker Therapeutics 10K Form

Sell
26

MRKR
Marker Therapeutics

Last Price:
2.81
Seasonality Move:
-21.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MRKR News And Ratings

See the #1 stock for the next 7 days that we like better than MRKR

MRKR Financial Statistics

Sales & Book Value

Annual Sales: $5.5M
Cash Flow: $-3.57M
Price / Cash Flow: 0
Annual Sales: $1.09
Price / Book: 2.57

Profitability

EPS (TTM): -1.18000
Net Income (TTM): $-10.37M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Marker Therapeutics Earnings Forecast

Key Marker Therapeutics Financial Ratios

  • The Selling, General & Administrative Expenses for MRKR have been equal to 206.11% of Gross Profit Margin.
  • The Interest Expense is -0.03% of Operating Income.
  • Per Share Earnings over the last 17 years have been positive in 11 years.

Marker Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MRKR
CUSIP: 57055L
Website: http//www.markertherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MRKR Technical Analysis vs Fundamental Analysis

Sell
26
Marker Therapeutics (MRKR) is a Sell

Is Marker Therapeutics a Buy or a Sell?